Prosecution Insights
Last updated: August 16, 2026

Georgia State University Research Foundation Inc.

8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (62%)
3
Medium (38%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (12%)
§103 only2 (25%)
Double-patenting + other1 (12%)
Multi-statute (no §101)4 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
25% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUTCHLER, CHRISTOPHER JOHN 1 55.4% +22.2%
MCCALL SHEPARD, SONYA D 1 92.9% +3.8%
CHANDRAKUMAR, NIZAL S 1 72.7% +18.3%
BORI, IBRAHIM D 1 44.2% +38.7%
BULLINGTON, ROBERT P 1 42.7% +30.3%
DONOHUE, SEAN R 1 41.4% +21.1%
SWIFT, CANDICE LEE 1 57.4% +36.7%
DICKINSON, PAUL W 1 62.8% +9.9%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18551277 Systems and Methods for Predicting Behavioral Traits BULLINGTON, ROBERT P 1d overdue
17610892 SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS DICKINSON, PAUL W 12d
18875299 LEADLESS IMPLANTABLE MEDICAL DEVICES MUTCHLER, CHRISTOPHER JOHN
18714464 FLEXIBLE AND MINIATURIZED COMPACT VERTICAL COLOR SENSOR MCCALL SHEPARD, SONYA D
18286191 GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES BORI, IBRAHIM D

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18123236 Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy DONOHUE, SEAN R 2d overdue
18551277 Systems and Methods for Predicting Behavioral Traits BULLINGTON, ROBERT P 1d overdue
18875299 LEADLESS IMPLANTABLE MEDICAL DEVICES MUTCHLER, CHRISTOPHER JOHN
18577529 THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS CHANDRAKUMAR, NIZAL S
18286191 GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES BORI, IBRAHIM D
18012252 PLASTIC POLYMER BIOCONVERSION PROCESS SWIFT, CANDICE LEE

Top Art Units

Art UnitApps
1618 2
3796 1
1625 1
1629 1
3715 1
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18875299 LEADLESS IMPLANTABLE MEDICAL DEVICES MUTCHLER, CHRISTOPHER JOHN 3796 §102§103§112 Non-Final OA Pending Dec 16, 2024
18714464 FLEXIBLE AND MINIATURIZED COMPACT VERTICAL COLOR SENSOR MCCALL SHEPARD, SONYA D §102§103 Non-Final OA Pending May 29, 2024
18577529 THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS CHANDRAKUMAR, NIZAL S 1625 §103 Non-Final OA Pending Jan 08, 2024
18286191 GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES BORI, IBRAHIM D 1629 §102§103 Non-Final OA Pending Oct 09, 2023
18551277 Systems and Methods for Predicting Behavioral Traits BULLINGTON, ROBERT P 3715 §101§112 Final Rejection 1d overdue Pending Sep 19, 2023
18123236 Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy DONOHUE, SEAN R 1618 §103 Non-Final OA 2d overdue Pending Mar 17, 2023
18012252 PLASTIC POLYMER BIOCONVERSION PROCESS SWIFT, CANDICE LEE 1657 §103§112DP Final Rejection Pending Dec 22, 2022
17610892 SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS DICKINSON, PAUL W 1618 §103§112 Final Rejection 12d Pending Nov 12, 2021

Managing Georgia State University Research Foundation Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month